Recall of CareLink Monitor and CareLink Express Monitor(used to gather information from an implanted heart device and transmit this information to the individual’s healthcare professional)

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Medtronic Australasia Pty Ltd.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2016-RN-00414-1
  • Event Risk Class
    Class II
  • Event Initiated Date
    2016-04-12
  • Event Country
  • Event Source
    DHTGA
  • Event Source URL
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    A recent software update for selected carelink/carelink express monitors included an incorrect telephone number. the telephone number is used when the home monitor is transmitting information to the carelink network. therefore, monitors that have received this update may no longer be able to transmit information, including carealerts, as well as receiving future software updates. the matter does not affect the continued safe operation of an individual’s implant in the immediate term. however if not addressed, a continued inability to connect to the carelink network may cause premature battery depletion for the implant. in a worst case scenario, the reported issue may result in early surgery to replace the implant and/or a reduction in the extended service period.
  • Action
    For affected clinics/patients, Medtronic will arrange for the delivery of a cellular or internet accessory to connect to the patients’ existing monitor to restore the functionality of the affected units. This action has been closed out on 20/01/2017.

Device

  • Model / Serial
    CareLink Monitor and CareLink Express Monitor(used to gather information from an implanted heart device and transmit this information to the individual’s healthcare professional)Model Numbers: 2020B and 2490CARTG Numbers: 116038 and 193374
  • Manufacturer

Manufacturer

  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    DHTGA